Skip to main content
$127.28 -$6.24 (-4.7%)

04:00 PM EST on 02/25/21

CRISPR Therapeutics (NASDAQ:CRSP)

CAPS Rating: 4 out of 5

Current Price $127.28 Mkt Cap $10.1B
Open $131.42 P/E Ratio 0.00
Prev. Close $127.28 Div. (Yield) $0.00 (0.0%)
Daily Range $123.70 - $135.12 Volume 2,147,170
52-Wk Range $32.30 - $220.20 Avg. Daily Vol. 2,510,089

Caps

How do you think NASDAQ:CRSP will perform against the market?

Add Stock to CAPS Watchlist

All Players

370 Outperform
7 Underperform
 

All-Star Players

197 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CRSP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

tomfoolme (75.86)
Submitted December 29, 2020

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. It develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CRSP VS S&P 500 (SPY)

NASDAQ:CRSP Summary

Fools bullish on NASDAQ:CRSP are also bullish on:

Fools bearish on NASDAQ:CRSP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CRSP.

Recs

0
Member Avatar Hsabol6 (35.97) Submitted: 2/24/2021 7:21:59 PM : Outperform Start Price: $131.81 NASDAQ:CRSP Score: -1.28

This technology is still stigmatized but there will be a change in public sentiment as people see the benefit of gene editing.

Recs

0
Member Avatar 1russianguy (97.05) Submitted: 2/23/2021 1:00:40 PM : Outperform Start Price: $143.53 NASDAQ:CRSP Score: -9.53

best of us investors, best growth potential for next 3 years

Recs

0
Member Avatar johnny05 (30.02) Submitted: 2/17/2021 7:06:12 PM : Outperform Start Price: $150.13 NASDAQ:CRSP Score: -13.36

Great price to enter this genomics Leader!

Leaderboard

Find the members with the highest scoring picks in CRSP.

Score Leader

CMFMLove

CMFMLove (83.54) Score: +745.99

I'm generally bad at CAPS but I may have gotten this pick right. There's a long way to go, however, until we see commercial results from this technology.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
CMFMLove 83.54 6/13/2017 Outperform 5Y $14.10 +802.70% +56.71% +745.99 1 Comment
Momentum21 74.52 10/24/2016 Outperform 5Y $14.05 +805.91% +78.01% +727.90 0 Comment
Playa14 34.74 6/9/2017 Outperform 5Y $15.13 +741.24% +56.63% +684.61 0 Comment
prankjt17530 75.97 2/13/2017 Outperform 5Y $15.21 +736.82% +64.74% +672.08 0 Comment
SHOPNVDA < 20 6/26/2017 Outperform 5Y $16.84 +655.82% +56.76% +599.06 0 Comment
Capitalism 94.79 5/15/2017 Outperform 5Y $17.05 +646.51% +59.22% +587.29 1 Comment
TMFFishBiz 70.08 11/13/2017 Outperform 5Y $17.91 +610.66% +48.02% +562.64 0 Comment
JF9383 84.23 12/6/2017 Outperform 5Y $18.44 +590.24% +45.44% +544.79 0 Comment
jeepdrew222 87.63 12/12/2017 Outperform 5Y $18.61 +583.93% +43.43% +540.51 0 Comment
portefeuille 98.72 3/27/2017 Outperform 5Y $18.50 +588.00% +64.85% +523.15 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRSP.